Clinical trial
A Double Blind Study for the Treatment of Acute Ulcerative Colitis
NCT00350415 · Warner Chilcott, Industry · Completed
Key facts
| NCT number | NCT00350415 |
|---|---|
| Title | A Double Blind Study for the Treatment of Acute Ulcerative Colitis |
| Official title | A Double-blind, Randomized, 6-week, Parallel-group Design Clinical Trial to Assess the Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day for the Treatment of Moderately Active Ulcerative Colitis. |
| Lead sponsor | Warner Chilcott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ulcerative Colitis |
| Intervention type | Drug |
| Interventions | Mesalamine |
| Enrollment | 772 |
| Start date | Jun 1, 2006 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Jul 10, 2006 |
| Last update posted | Apr 17, 2013 |
| Countries | Belarus, Canada, Croatia, Czechia, Estonia, Hungary, Latvia, Lithuania, Poland, Puerto Rico, Romania, Russia and 3 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: